Actualizaciones
-
06 diciembre 2022
C19RM Extension, Reinvestments and Portfolio Optimization
Over the last 6 months as the COVID-19 pandemic evolved, the Global Fund observed a shift in funding priorities in implementing countries, from emergency pandemic response to strengthening systems for health, pandemic preparedness, and recovery of HI... -
14 octubre 2022
Achieving Global Goals Together
Following the Global Fund’s Seventh Replenishment, the Global Fund convened a high-level roundtable entitled “Achieving Global Goals Together”. The event brought together leadership of Country Coordinating Mechanisms and Principal Recipients for an ... -
16 noviembre 2021
Inequitable Access to COVID-19 Tools is Hindering the Pandemic Response
A new snapshot reveals the persistent and glaring inequity in access to lifesaving COVID-19 tools, such as diagnostic tests, treatments (including medical oxygen), and personal protective equipment (PPE), that is hindering the pandemic response in lo... -
03 noviembre 2021
Briefing Note: Testing for both Tuberculosis and SARS-CoV-2
The new Briefing Note on Testing for both Tuberculosis and SARS-CoV-2 is now available, also in French and Spanish. It provides information for TB programs including testing for both diseases. -
03 septiembre 2021
Accelerating Procurement of Approved Health Products under C19RM - COVID-19 Response Mechanism
Principal Recipients are requested to accelerate the procurement of approved health products under C19RM awards through both Pooled Procurement Mechanism (PPM) and non-PPM channels to ensure rapid availability in their countries. -
17 agosto 2021
The ACT-Accelerator: Diagnostics Pillar Update
Testing is the first line of defense in the fight against COVID-19. Without testing, countries cannot track or contain the spread of the virus, address urgent clinical needs, test the efficacy of vaccines, or detect the emergence of new variants.